Navigation Links
Verenium Reports Financial Results For The Third Quarter And Nine Months Ended September 30, 2012
Date:11/8/2012

SAN DIEGO, Nov. 8, 2012 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today reported operating highlights and financial results for the third quarter and nine months ended September 30, 2012.

(Logo: http://photos.prnewswire.com/prnh/20120924/MM79973LOGO)

"During the third quarter we made some important steps forward with our manufacturing investment program; however, the downtime experienced in manufacturing due to these upgrades combined with the continued unfavorable market conditions in corn ethanol, made this a challenging quarter financially," said James Levine, President & Chief Executive Officer at Verenium. "Despite the impact on our margins this period, we remain confident that the enhancements we are making now in our manufacturing platform, as well as our high-performance product portfolio, our current Product Pipeline and our strategy for diversifying our revenue through products for new end markets, will support our growth in the future."

Company HighlightsSince the beginning of 2012, the Company has made progress on both operational and financial fronts.  Recent accomplishments include:

  • Implemented manufacturing improvements that resulted in greater Fuelzyme® alpha-amylase yields and reduced manufacturing costs;
  • Presented a co-authored scientific paper reporting on our findings from research conducted with the Company's next-generation Pyrolase® HT cellulase product for breaking cross-linked fracturing fluids under extreme downhole conditions in hydraulic fracturing;
  • Ended the third quarter with unrestricted cash of $13.9 million and $4.1 million in restricted cash.
  • Financ
    '/>"/>

    SOURCE Verenium Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related medicine technology :

    1. Verenium To Present At The Deutsche Bank 2012 Clean Tech, Utilities & Power Conference
    2. Verenium To Present At The Jefferies 2012 Global Industrial And Aerospace & Defense Conference
    3. Verenium To Present At Upcoming Conferences
    4. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
    5. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
    6. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
    7. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
    8. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
    9. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
    10. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
    11. Luminex Corporation Reports First Quarter 2012 Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/27/2015)... , March 27, 2015  WebMD Health ... source of health information, today announced an ... National Action Plan for Combating Antibiotic-Resistant ... emphasized the urgency and importance of addressing ... and global health.    The WebMD ...
    (Date:3/26/2015)... March 26, 2015 Huntington Memorial Hospital is ... perform transcatheter aortic valve replacement (TAVR), a minimally invasive ... revolutionary new way to replace an aortic valve without ... lung machine. The procedure is performed by ... Azhil ( Alex) Durairaj , MD, interventional cardiologist and ...
    (Date:3/26/2015)... OAK, Mich. , March 26, 2015 ... have performed the Midwest,s first commercial implant of ... Administration for patients with non-valvular atrial fibrillation. The Watchman ... long-term use of blood-thinning warfarin medication to reduce the ... most common heart rhythm disorder affecting more than 5 ...
    Breaking Medicine Technology:Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 2Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 3Huntington Memorial Hospital Performs Groundbreaking Minimally Invasive Replacement of Heart Valves 2Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 2Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 3
    ... Inc. (Nasdaq: ISTA ), today announced the ... Company,s supplemental New Drug Application (sNDA) for BROMDAY™ (bromfenac ... for the treatment of postoperative inflammation and reduction of ...  ISTA expects to launch BROMDAY (formerly referred to as ...
    ... 15 The U.S. Food and Drug Administration ... in adult patients with chronic migraine. Chronic migraine is ... on most days of the month. ... http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO )   "Chronic migraine ...
    Cached Medicine Technology:ISTA Pharmaceuticals Receives FDA Approval for BROMDAY™ 2ISTA Pharmaceuticals Receives FDA Approval for BROMDAY™ 3ISTA Pharmaceuticals Receives FDA Approval for BROMDAY™ 4FDA Approves Botox to Treat Chronic Migraine 2
    (Date:3/28/2015)... (PRWEB) March 28, 2015 Emergency Medical ... urgent care in Manhattan, recently commemorated its three-year anniversary ... in Manhattan. In addition to 24-hour urgent care, Emergency ... , At this time, Emergency Medical Care’s ... pain, asthma, chest pain, eye injuries, ear infections, fevers, ...
    (Date:3/28/2015)... Las Vegas, NV (PRWEB) March 28, 2015 ... surgery experiences re-injury, according to research presented today at ... ) Specialty Day. The study examined the long term ... younger. , “We examined survey data from 242 ... noted lead author Justin P. Roe, MBBS, FRACS, from ...
    (Date:3/28/2015)... Andrew Hawley of Vintage Rock Posters Inc., ... posters. The Who and the Doors played together at the ... According to Hawley, “The Who toured the United States heavily ... campuses. Perhaps the most famous Who poster was a poster ... Doors on August 2, 1968 at the Singer Bowl in ...
    (Date:3/28/2015)... March 28, 2015 Designers and Professionals ... overlay entitled Scratches 5K from Pixel Film Studios. , ... to any media inside Final Cut Pro X” Said ... saves time and is an effective tool for any ... Overlay Scratches 5K's intuitive grunge overlays. Simply drag title ...
    (Date:3/27/2015)... 2015 The Monogamy Method ... Samantha Sanderson and Jason Rogers has just been released ... attention. The commotion surrounding the course's launch has caught ... publish an in-depth review of the new program. , ... in their lives suddenly start pulling away or expressing ...
    Breaking Medicine News(10 mins):Health News:Emergency Medical Care Celebrates Three Years of 24/7 Walk-In Urgent Care Services 2Health News:Young Athletes at Greater Risk for Re-Injury after ACL Surgery 2Health News:Avid Collector from Vintage Rock Posters, Inc. Announces His Search For Original 1960's Who Psychedelic Concert Posters. 2Health News:Pixel Film Studios Unveiled Scratches 5k for Final Cut Pro X Editors 2Health News:The Monogamy Method - Review Of Samantha Sanderson & Jason Rogers' Relationship Program Released 2
    ... executives to add anti-smoking public service announcements to all ... contactmusic.com, Maryland Attorney General // Joseph Curran initiated the ... who watch smoking in movies are more likely to ... to also sign their names on a letter he ...
    ... of having produced and purified stem cells from human embryos ... the British medical fraternity. ,The Guardian reported Friday that ... tighter curbs on clinics in India that make extravagant claims ... whose claims have evoked some concern here is Geeta Shroff, ...
    ... What some Japanese newly licensed therapists do is no ... laugh!, ,The first 49 laughing therapists recently passed ... patients laugh to improve their immune system, and in ... professor and pediatrician at the organizing Nihon Medical School., ...
    ... (BBW) issued for high-risk medication by the FDA, doctors have ... The percentage of patients found to receive // such ... Harvard Medical School and Harvard Pilgrim Health Care. ,The ... BBWs was highly variable, with noncompliance rates soaring from 0.3 ...
    ... King County Superior Court jury in Seattle, Dr. Charles Momah, ... counts // of rape and two counts of indecent liberties ... ,Momah could face 16 years in prison if convicted ... ,Momah pleaded not guilty last year to two counts of ...
    ... mother-to-son nerve transplant on Thursday, hoping to restore the use ... Anderson of Atco, N.J., went as planned, and doctors // ... months, said Eric Vohr, a spokesman for Johns Hopkins Hospital. ... months, in about a year they should know if he'll ...
    Cached Medicine News:Health News:British Scientists Doubt Delhi Doctor’s Stem Cell Claim 2Health News:Are You Ill? Have A Hard Laugh! 2Health News:Doctors Do Not Excise Sufficient Caution While Prescribing High-Risk Drugs 2Health News:Doctors Finish Mother-To-Son Nerve Surgery 2
    Mylar Plate Sealers 100/Box...
    OptiTape individual sheets. Optically clear sealing tape for OmniUltra PCR plates. 100 pk....
    TD silicone foam compression pad. Use with plates sealed with TDX or OptiTape....
    TDX Tape - sealing sheets for polypropylene plates only, 100/PK...
    Medicine Products: